T1	Participants 99 136	patients with advanced breast cancer:
T2	Participants 275 305	metastatic breast cancer (MBC)
T3	Participants 477 519	anthracycline-pretreated patients with MBC
T4	Participants 1847 1886	women with anthracycline-pretreated MBC
